Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

Author: D. Carlson, M. Hinchcliff, J. Pandolfino
Date Published: December-2014
Source: Current Rheumatology Reports

Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and esophageal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastroesophageal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions.